Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7).

Colomban O, Tod M, Peron J, Perren TJ, Leary A, Cook AD, Sajous C, Freyer G, You B.